Bevafize Trademark Details

This mark is alive with a status of First Extension - Granted. The last case file activity for this mark occured 7 years ago on Friday, June 10, 2016, according to the United State Patent & Trademark Office
Word Mark Bevafize
Status Alive 730 — First Extension - Granted
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 86662882
Status Date Friday, June 10, 2016
Filing Date Friday, June 10, 2016
Attorney Janina Gorbach

Correspondent

Janina Gorbach
Pfizer Inc.
235 East 42nd Street
New York NY 10017

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, June 18, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.